chr3-49532782-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004393.6(DAG1):​c.2271C>T​(p.Ala757Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00172 in 1,614,062 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 18 hom. )

Consequence

DAG1
NM_004393.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.83

Publications

3 publications found
Variant links:
Genes affected
DAG1 (HGNC:2666): (dystroglycan 1) This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015]
DAG1 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2P
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • isolated asymptomatic elevation of creatine phosphokinase
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 3-49532782-C-T is Benign according to our data. Variant chr3-49532782-C-T is described in ClinVar as Benign. ClinVar VariationId is 383114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.83 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00741 (1129/152320) while in subpopulation AFR AF = 0.0247 (1025/41566). AF 95% confidence interval is 0.0234. There are 16 homozygotes in GnomAd4. There are 543 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004393.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DAG1
NM_004393.6
MANE Select
c.2271C>Tp.Ala757Ala
synonymous
Exon 3 of 3NP_004384.5Q14118
DAG1
NM_001165928.4
c.2271C>Tp.Ala757Ala
synonymous
Exon 6 of 6NP_001159400.3Q14118
DAG1
NM_001177634.3
c.2271C>Tp.Ala757Ala
synonymous
Exon 6 of 6NP_001171105.2Q14118

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DAG1
ENST00000308775.7
TSL:1 MANE Select
c.2271C>Tp.Ala757Ala
synonymous
Exon 3 of 3ENSP00000312435.2Q14118
DAG1
ENST00000418588.6
TSL:3
c.2271C>Tp.Ala757Ala
synonymous
Exon 4 of 4ENSP00000405859.2Q14118
DAG1
ENST00000421560.6
TSL:4
c.2271C>Tp.Ala757Ala
synonymous
Exon 3 of 3ENSP00000412067.2Q14118

Frequencies

GnomAD3 genomes
AF:
0.00739
AC:
1125
AN:
152202
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00229
AC:
574
AN:
250346
AF XY:
0.00184
show subpopulations
Gnomad AFR exome
AF:
0.0269
Gnomad AMR exome
AF:
0.00211
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000301
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00113
AC:
1648
AN:
1461742
Hom.:
18
Cov.:
34
AF XY:
0.00106
AC XY:
772
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.0279
AC:
934
AN:
33480
American (AMR)
AF:
0.00239
AC:
107
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00184
AC:
48
AN:
26136
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39700
South Asian (SAS)
AF:
0.000243
AC:
21
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53288
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
0.000323
AC:
359
AN:
1112006
Other (OTH)
AF:
0.00245
AC:
148
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
119
238
356
475
594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00741
AC:
1129
AN:
152320
Hom.:
16
Cov.:
32
AF XY:
0.00729
AC XY:
543
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.0247
AC:
1025
AN:
41566
American (AMR)
AF:
0.00372
AC:
57
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68026
Other (OTH)
AF:
0.00805
AC:
17
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
56
112
169
225
281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00356
Hom.:
2
Bravo
AF:
0.00804
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9;C4511963:Autosomal recessive limb-girdle muscular dystrophy type 2P (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.32
DANN
Benign
0.55
PhyloP100
-3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78281659; hg19: chr3-49570215; API